Menu
GWAS Study

Genome-Wide Meta-Analysis Identifies Two Novel Risk Loci for Epilepsy.

Song M, Liu J, Yang Y et al.

34456681 PubMed ID
GWAS Study Type
800869 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SM
Song M
LJ
Liu J
YY
Yang Y
LL
Lv L
LW
Li W
LX
Luo XJ
Chapter II

Abstract

Summary of the research findings

Epilepsy (affects about 70 million people worldwide) is one of the most prevalent brain disorders and imposes a huge economic burden on society. Epilepsy has a strong genetic component. In this study, we perform the largest genome-wide meta-analysis of epilepsy (N = 8,00,869 subjects) by integrating four large-scale genome-wide association studies (GWASs) of epilepsy. We identified three genome-wide significant (GWS) (p < 5 × 10-8) risk loci for epilepsy. The risk loci on 7q21.11 [lead single nucleotide polymorphism (SNP) rs11978015, p = 9.26 × 10-9] and 8p23.1 (lead SNP rs28634186, p = 4.39 × 10-8) are newly identified in the present study. Of note, rs11978015 resides in upstream of GRM3, which encodes glutamate metabotropic receptor 3. GRM3 has pivotal roles in neurotransmission and is involved in most aspects of normal brain function. In addition, we also identified three genes (TTC21B, RP11-375N15.2, and TNKS) whose cis-regulated expression level are associated with epilepsy, indicating that risk variants may confer epilepsy risk through regulating the expression of these genes. Our study not only provides new insights into genetic architecture of epilepsy but also prioritizes potential molecular targets (including GRM3 and TTC21B) for development of new drugs and therapeutics for epilepsy.

19,122 European ancestry cases, 168,998 European ancestry controls, 2,143 Japanese ancestry cases, 210,310 Japanese ancestry controls, 5,087 cases, 395,209 controls

Chapter III

Study Statistics

Key metrics and study information

800869
Total Participants
GWAS
Study Type
No
Replicated
European, East Asian
Ancestry
Japan, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.